Q2 2025 Rockwell Medical Inc Earnings Call Transcript
Key Points
- Rockwell Medical Inc (RMTI) improved its cash position and was cash flow positive from operations in the second quarter.
- The company has signed several new contracts and renewed existing ones, with over 80% of customers now under long-term agreements.
- Rockwell Medical Inc (RMTI) remains a leading supplier of liquid bicarbonate products in the United States, maintaining strategic value.
- The company has entered into a multi-million dollar purchase agreement with Innovative Renal Care, enhancing its customer base.
- Rockwell Medical Inc (RMTI) has diversified its customer base, reducing concentration risk significantly from previous years.
- Net sales for the second quarter decreased by 38% compared to the same period in 2024, primarily due to the largest customer transitioning to another supplier.
- Gross profit for the second quarter fell by 45% compared to the same period in 2024.
- The company reported a net loss of $1.5 million for the second quarter, a decline from a net income of $300,000 in the same period in 2024.
- Adjusted EBITDA for the second quarter was negative $200,000, a decline from a positive adjusted EBITDA of $1.4 million in Q2 2024.
- The company is still in negotiations with its largest customer, which could impact financials if a long-term agreement is not reached.
Good morning and welcome to Rockwell Medical's Second quarter 2025 results conference call and webcast. Please note this event is being recorded.
At this time, I would like to turn the conference call over to Heather R. Hunter, Senior Vice President, Chief Corporate Affairs Officer at Rockwell Medical. Heather, please go ahead.
Good morning and thank you for joining us for this update on Rockwell Medical. Joining me on today's conference call are Dr. Mark Strobeck, Rockwell Medical's President and Chief Executive Officer, and Jesse Neri, Rockwell Medical's Chief Financial Officer.
Before we begin, I would like to remind you that this conference call will contain forward-looking statements about Rockwall Medical within the meaning of the Federal Securities laws, including but not limited to the types of statements identified as forward-looking in our annual report on Form-10k. And are subsequent periodic reports filed with the SEC. These statements
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
